Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Obstet Gynecol MFM ; 2(4): 100204, 2020 11.
Article in English | MEDLINE | ID: mdl-33345920

ABSTRACT

BACKGROUND: Studies have shown an association between the incidence of gestational diabetes and living in neighborhoods oversaturated with unhealthy foods. OBJECTIVE: This study sought to determine if the food environment also affects the management of gestational diabetes. We hypothesized that living in areas with a higher quality of food decreased the risk of requiring medication to treat gestational diabetes. STUDY DESIGN: This was a retrospective cohort study of singleton births at the Christiana Care Health System between 2015 and 2018. Patients with gestational diabetes who live in Delaware (N=1327) were geocoded and classified according to their census tract food environment. The food environment was assessed using the modified Retail Food Environment Index, which measures the percentage of healthy food retailers among all food retailers within a half-mile radius of the census tract boundaries. The modified Retail Food Environment Index scores were divided into 3 categories: poor (modified Retail Food Environment Index score, 0-3), average (modified Retail Food Environment Index score, 4-10), and good or above average (modified Retail Food Environment Index score, ≥11) food environments. The primary outcome was the prevalence of A2 gestational diabetes mellitus. Several neonatal and obstetrical outcomes were also examined including type II diabetes mellitus (defined as a 2-hour glucose tolerance test with at least 1 value above the threshold), cesarean delivery, shoulder dystocia, admission to the neonatal intensive care unit, neonatal hypoglycemia, neonatal hyperbilirubinemia, neonatal respiratory distress syndrome, and macrosomia. RESULTS: A total of 689 (52%) women were diagnosed as having A2 gestational diabetes mellitus. Women in the average or good or above average food environment groups had a lower prevalence of A2 gestational diabetes mellitus than women in the poor food environment group (modified Retail Food Environment Index score, 4-10 [adjusted odds ratio, 0.58; 95% confidence interval, 0.37-0.92] and modified Retail Food Environment Index score, ≥11 [adjusted odds ratio, 0.56; 95% confidence interval, 0.40-0.82]). They also had a lower prevalence of type II diabetes mellitus (modified Retail Food Environment Index score, 4-10 [adjusted odds ratio, 0.25; 95% confidence interval, 0.09-0.72] and modified Retail Food Environment Index score, ≥11 [adjusted odds ratio, 0.48; 95% confidence interval, 0.27-0.86]). There were no differences in the other secondary outcomes of interest. CONCLUSION: The food environment affects the requirement for medication to obtain glycemic levels that are within the target range for those with gestational diabetes.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetes, Gestational , Cesarean Section , Diabetes, Gestational/epidemiology , Female , Fetal Macrosomia , Humans , Infant, Newborn , Pregnancy , Retrospective Studies
2.
Am J Obstet Gynecol ; 222(4): 338.e1-338.e5, 2020 04.
Article in English | MEDLINE | ID: mdl-31962106

ABSTRACT

Prior authorization is a process requiring health care providers to obtain advance approval from a payer before a patient undergoes a procedure for the study to be covered. Prior authorization was introduced to decrease overutilization of ultrasound procedures. However, it has led to unanticipated consequences such as impeding access to obstetric imaging, increased administrative overhead without reimbursement, and contribution to physician frustration and burnout. Payers often use intermediary radiology benefit management companies without providing specialty-specific review in a timely manner as is requisite when practicing high-risk obstetrics. This article proposes a number of potential solutions to this problem: (1) consider alternative means to monitor overutilization; (2) create and evaluate data regarding providers in the highest utilization; (3) continue to support and grow the educational efforts of speciality societies to publish clinical guidelines; and (4) emphasize the importance of practicing evidence-based medicine. Understanding that not all health plans may be willing or able to collaborate with health care providers, we encourage physicians to advocate for policies and legislation to limit the implementation of prior authorization within their own states.


Subject(s)
Health Services Accessibility , Medical Overuse/prevention & control , Prior Authorization/organization & administration , Quality of Health Care , Ultrasonography, Prenatal , Conflict of Interest , Female , Guideline Adherence , Humans , Practice Guidelines as Topic , Pregnancy , Prior Authorization/economics , Prior Authorization/ethics , Prior Authorization/legislation & jurisprudence , Time Factors , Ultrasonography, Prenatal/standards
SELECTION OF CITATIONS
SEARCH DETAIL
...